Thiamine and benfotiamine improve cognition and ameliorate GSK-3β-associated stress-induced behaviours in mice.
Thiamine (vitamin B1) deficiency in the brain has been implicated in the development of dementia and symptoms of depression. Indirect evidence suggests that thiamine may contribute to these pathologies by controlling the activities of glycogen synthase kinase (GSK)-3β. While decreased G...
Main Authors: | Markova, N, Bazhenova, N, Anthony, D, Vignisse, J, Svistunov, A, Lesch, K, Bettendorff, L, Strekalova, T |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Elsevier
2016
|
פריטים דומים
-
Thiamine and benfotiamine prevent stress-induced suppression of hippocampal neurogenesis in mice exposed to predation without affecting brain thiamine diphosphate levels
מאת: Vignisse, J, et al.
יצא לאור: (2017) -
Thiamine and benfotiamine: Focus on their therapeutic potential
מאת: Iva Bozic, et al.
יצא לאור: (2023-11-01) -
Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules
מאת: O. A. Gromova, et al.
יצא לאור: (2017-07-01) -
Benfotiamine Supplementation Increases Thiamine in Muscle of Endurance-Trained Mice and Affects the Energy Metabolism
מאת: Álisson C. Gonçalves, et al.
יצא לאור: (2024-01-01) -
Paraptosis cell death induction by the thiamine analog benfotiamine in leukemia cells.
מאת: Naomi Sugimori, et al.
יצא לאור: (2015-01-01)